Market Analysis
Jamie Dimon Says AI Will Impact ‘Virtually Every Function’ at JPMorgan
Jamie Dimon: AI Will Impact Every Function at JPMorgan
Total Stories
2,790
News
Market Analysis
Section
Market Analysis
Market Analysis
Why is Palantir Stock Down Today? Anthropic AI FUD Triggers PLTR Stock Sell-Off
Michael Burry Slams Palantir Amid Anthropic AI Threat
Market Analysis
European Markets Stumble as Iran Deadline Injects War Premium into Energy
European Markets Fall as Iran Deadline Spikes Energy Prices
Market Analysis
Lyft Stock Surge as Analysts Cite ‘Rationalized’ Pricing and Margin Expansion
Why Is Lyft (LYFT) Stock Surging Today?
Market Analysis
S&P 500 and Nasdaq Futures Drop After Trump Warns Iran Conflict ‘Not Over’
S&P 500 and Nasdaq Futures Slide on Trump Iran Comments
Market Analysis
The Largest in History: Elon Musk’s SpaceX Files Confidentially for IPO at $1.75 Trillion Valuation
SpaceX IPO Filing: $1.75T Valuation, Market Implications
Market Analysis
Bitcoin ETFs Extend Inflows With $118 Million as Ether Adds $31 Million
Bitcoin ETFs Pull $118M, Ether Funds Add $31M in Inflows
Market Analysis
Yield Curve Steepening: How the 10Y Treasury Surge Is Testing Dividend Aristocrats
10Y Treasury Surge Pressures S&P 500 Dividend Aristocrats
Market Analysis
Why Is Nvidia Stock Higher Premarket? China Approves AI Chip Sales
NVIDIA stock is rising premarket after Beijing approved sales of its H200 AI chips to China, allowing the company to restart production and resume shipments after…
Market Analysis
AMD Stock Rises Premarket Today as Samsung Partnership Expands
AMD stock is rising in premarket trading after the company and Samsung Electronics signed an MoU to expand their AI memory partnership.
Market Analysis
Why Is Qualcomm (QCOM) Stock Moving Higher Today? $20B Buyback Plan
Qualcomm stock is rising Tuesday after the company announced a $20 billion stock buyback program and raised its quarterly dividend from $0.89 to $0.92 per share.
Market Analysis
Dividend Aristocrats Defying Gravity: How Coca-Cola and McDonald’s Are Quietly Crushing the Market in 2026
In a year defined by geopolitical chaos, AI disruption fears, and energy market shocks, two iconic dividend aristocrats are delivering double-digit returns while the broader market…
Market Analysis
Why Is ImmunityBio (IBRX) Stock Jumping Today? ANKTIVA Gains NCCN Backing
ImmunityBio (IBRX) stock jumped over 6% in premarket trading after the NCCN added ANKTIVA to its bladder cancer guidelines, expanding its use.